A study in the November issue of Gastroenterology looks at the risk of nonmelanoma skin cancer (NMSC) among individuals with inflammatory bowel disease (IBD), including those with or without exposure to immunosuppressant medications. Dr. Kuemmerle speaks to author Dr. Harminder Singh of the University of Manitoba; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.